SUBSTITUTED THIAZOLE LINKED MURRAYANINE-SCHIFF’S BASE DERIVATIVES AS POTENTIAL ANTI-BREAST CANCER CANDIDATES: FUTURE EGFR KINASE INHIBITORS

Authors

  • Debarshi Kar Mahapatra Department of Pharmaceutical Chemistry, Dadasaheb Balpande College of Pharmacy, Nagpur 440037, Maharashtra, India
  • Devashish Das Department of Pharmaceutical Chemistry, Dadasaheb Balpande College of Pharmacy, Nagpur 440037, Maharashtra, India
  • Ruchi Shivhare Department of Pharmaceutical Chemistry, Kamla Nehru College of Pharmacy, Nagpur 441108, Maharashtra, India

Abstract

Cancer is the second leading causes of mortality across the planet which has had affected millions. In spite of massive efforts in producing new molecules and chemotherapeutic approaches for managing cancer, it continued to be the global threat. Small hybrid molecules have gained popularity in chemotherapy due to their potential and smart characteristics in modulating biological targets. The present research attempts in developing few novel hybridized derivatives of murrayanine (an active carbazole derivative) by the semi-synthetic approach to form substituted thiazole linked murrayanine-Schiff’s base derivatives. The protocol involved murrayanine 1 as the template material for constructing a hybridized Schiff’s base intermediate 3, which further by Hantzch’s cyclization was subsequently converted to various hybridized thiazoles analogs 5a-5f. The purity of the synthesized compounds was ascertained by sophisticated analytical techniques. The anti-cancer potential was screened against breast cancer cell lines; MCF-7 and MDA-MB-231 by Sulforhodamine B (SRB) assay. The compound 5b displayed most potent anti-proliferative activity with IC50 values of 23.41μM against MCF-7 cell line and 32.15μM against MDA-MB-231 cell line. It has been observed that analogs having electron withdrawing substituents exhibited pronounced anticancer activity. The docking study was performed by Autodock Vina where the results were found to be in full agreement with the cytotoxic study, depicting that the probable cytotoxic outcome by EGFR inhibitory mechanism. The study revealed the potential of novel hybridized derivatives as active anti-breast cancer candidates. The research will encourage (medicinal) chemists in rationally designing of semi-synthetic analogs of a heterocyclic prototype having pronounced anti-cancer activity.

Keywords:

Murrayanine, Thiazole, Schiff’s base, Carbazole, Cancer, EGFR.

DOI

https://doi.org/10.25004/IJPSDR.2017.090307

References

1. http://www.who.int/mediacentre/factsheets/fs297/en/ (accessed 11April, 2017).
2. Asati V, Mahapatra DK, Bharti SK. Thiazolidine-2, 4-diones as multi-targeted scaffold in medicinal chemistry: potential anticancer agents. European Journal of Medicinal Chemistry. 2014; 87:814-33.
3. Mahapatra DK, Bharti SK, Asati V. Anti-cancer chalcones: Structural and molecular target perspectives. European Journal of Medicinal Chemistry. 2015; 98:69-114.
4. Iyer D, Devi U. Phyto-pharmacology of Murraya koenigii (L.). Pharmacognosy Reviews. 2008; 2(3):180.
5. Nayak A, Mandal S, Banerji A, Banerji J. Review on chemistry and pharmacology of Murraya koenigii Spreng (Rutaceae). Journal of Chemical and Pharmaceutical Research. 2010; 2(2):286-99.
6. Adebajo AC, Olayiwola G, Eugen Verspohl J, Iwalewa EO, Omisore NO, Bergenthal D, Kumar V, Kolawole Adesina S. Evaluation of the Ethnomedical Claims of Murraya koenigii. Pharmaceutical Biology. 2005; 42(8):610-620.
7. Rao KV, Schwartz SA, Nair HK, Aalinkeel R, Mahajan S, Chawda R, Nair MP. Plant derived products as a source of cellular growth inhibitory phytochemicals on PC-3M, DU-145 and LNCaP prostate cancer cell lines. Current Science. 2004; 87(11):1585-1588.
8. Ajay S, Rahul S, Sumit G, Paras M, Mishra A, Gaurav A. Comprehensive review: Murraya koenigii Linn. Asian Journal of Pharmacy and Life Science 2011; 2231:4423.
9. Nagappan T, Ramasamy P, Wahid ME, Segaran TC, Vairappan CS. Biological activity of carbazole alkaloids and essential oil of Murraya koenigii against antibiotic resistant microbes and cancer cell lines. Molecules. 2011; 16(11):9651-9664.
10. Sukari M, Aspollah M, Ismail N, Bakar A, Haslizawati N, Ithnin NL. Cytotoxic carbazole alkaloids from Murraya koenigii (Rutaceae). Research Journal of Chemistry and Environment. 2014; 18(11):8-11.
11. Fiebig M, Pezzuto JM, Soejarto DD, Kinghorn AD. Koenoline, a further cytotoxic carbazole alkaloid from Murraya koenigii. Phytochemistry. 1985; 24(12):3041-3.
12. Mohan S, Abdelwahab SI, Cheah SC, Sukari MA, Syam S, Shamsuddin N, Rais Mustafa M. Apoptosis effect of girinimbine isolated from Murraya koenigii on lung cancer cells in vitro. Evidence-Based Complementary and Alternative Medicine. 2013; 2013.
13. Kok YY. Cytotoxicity of Mahanimbine, Murryafoline A and S-Benzyldithiocarbazate on Human Leukemic Cell Line, CEM-SS (Doctoral dissertation, Universiti Putra Malaysia).
14. Handral HK, Pandith A, Shruthi SD. A review on Murraya koenigii: multipotential medicinal plant. Asian Journal of Pharmaceutical and Clinical Research. 2012; 5(4):5-14.
15. Mahapatra DK, Bharti SK. Computer assisted rational design and synthesis of some novel 2, 4-di-substitued thiazole derivatives and their metal complexes (copper, cobalt, and nickel) as inhibitor of bacterial metabolic enzymes. International Journal of Infectious Diseases. 2016; 45:126-7
16. Bharti SK, Mahapatra DK, Singh SK. Thiazole: A Simple Scaffold with Tremendous Therapeutic Potential. In: Chemical and Biochemical Engineering: New Materials and Developed Components. Apple Academic Press. 2015, pp. 43-64.
17. Bharti SK, Patel SK, Nath G, Tilak R, Singh SK. Synthesis, characterization, DNA cleavage and in vitro antimicrobial activities of copper (II) complexes of Schiff bases containing a 2, 4-disubstituted thiazole. Transition Metal Chemistry. 2010; 35(8):917-25.
18. Bharti SK, Nath G, Tilak R, Singh SK. Synthesis, anti-bacterial and anti-fungal activities of some novel Schiff bases containing 2, 4-disubstituted thiazole ring. European Journal of Medicinal Chemistry. 2010; 45(2):651-60.
19. Shivhare RS, Mahapatra DK, Nair RR, Deshmukh SN. Schiff’s base derivatives of murrayanine demonstrated enhanced anti-oxidant activity than its parent moiety. Indian Journal of Pharmaceutical Education and Research 2016; 50(3):9-15.
20. Bharti SK, Singh SK. Design, synthesis and biological evaluation of some novel benzylidene-2-(4-phenylthiazol-2-yl) hydrazines as potential anti-inflammatory agents. Medicinal Chemistry Research. 2014; 23(2):1004-15.
21. Asati V, Bajaj S, Mahapatra DK, Bharti SK. Molecular modeling studies of some thiazolidine-2, 4-dione derivatives as 15-PGDH inhibitors. Medicinal Chemistry Research. 2016; 25(1):94-108.
22. Wei H, Zhang X, Wu G, Yang X, Pan S, Wang Y, Ruan J. Chalcone derivatives from the fern Cyclosorus parasiticus and their anti-proliferative activity. Food and Chemical Toxicology. 2013; 60:147-52.

Published

01-05-2017
Statistics
Abstract Display: 465
PDF Downloads: 480
Dimension Badge

How to Cite

“SUBSTITUTED THIAZOLE LINKED MURRAYANINE-SCHIFF’S BASE DERIVATIVES AS POTENTIAL ANTI-BREAST CANCER CANDIDATES: FUTURE EGFR KINASE INHIBITORS”. International Journal of Pharmaceutical Sciences and Drug Research, vol. 9, no. 3, May 2017, pp. 139-44, https://doi.org/10.25004/IJPSDR.2017.090307.

Issue

Section

Research Article

How to Cite

“SUBSTITUTED THIAZOLE LINKED MURRAYANINE-SCHIFF’S BASE DERIVATIVES AS POTENTIAL ANTI-BREAST CANCER CANDIDATES: FUTURE EGFR KINASE INHIBITORS”. International Journal of Pharmaceutical Sciences and Drug Research, vol. 9, no. 3, May 2017, pp. 139-44, https://doi.org/10.25004/IJPSDR.2017.090307.